sevelamer_hydrochloride: profile and news

Genzyme Reports Financial Results for the First Quarter of 2006  Apr 19, 2006
Within the Renal division, revenue for Renagel(R) (sevelamer hydrochloride), a phosphate binder for patients with end-stage renal disease on hemodialysis, was ... - MSN Money

Fosrenol Significantly Reduces Tablet Burden for End-Stage Renal ...  Apr 21, 2006
Both patients and physicians preferred Fosrenol (lanthanum carbonate) over sevelamer hydrochloride (HCI) and calcium-based phosphate binders in a naturalistic ... - DG News

Forsenol reduces tablet burden on end stage renal disease patients ...  Apr 26, 2006
Both patients and physicians preferred FOSRENOL (lanthanum carbonate) over sevelamer hydrochloride (HCI) and calcium-based phosphate binders in a naturalistic ... - News-Medical.net,

Genzyme's First-Quarter Sales Below Expectations  Apr 19, 2006
...stock than with some others," he added, referring to 2001's inventory screw-up and temporary shortage of Renagel (sevelamer hydrochloride), Genzyme's phosphate ... - BioWorld Online (subscription),